Laurel Wealth Advisors (California)’s Galectin Therapeutics GALT Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio GALT Stock Details GALT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell
2019 Q1	$85K	Hold
2018 Q4	$56K	Hold
2018 Q3	$99K	Hold
2018 Q2	$105K	Sell
2018 Q1	$101K	Buy
2017 Q4	–	Sell
2017 Q3	$34K	Hold
2017 Q2	$39K	Buy
2017 Q1	$34K	Buy
2016 Q4	$9K	Buy